49
Participants
Start Date
October 1, 2025
Primary Completion Date
October 1, 2027
Study Completion Date
July 1, 2028
intraperitoneal chemotherapy
Through a peritoneal access port, irinotecan will be administered at the same time as systemic (chemo)therapy
Lead Sponsor
Catharina Ziekenhuis Eindhoven
OTHER
Netherlands Cancer Institute - NKI
UNKNOWN
Erasmus Medical Center
OTHER